Gene · 7433
Papers1,819
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,819
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hexon modification of human adenovirus type 5 vectors enables efficient transduction of human multipotent mesenchymal stromal cells. | Mol Ther Methods Clin Dev | 2022 | 35402633 | PubTator, text mining | PubMed |
| Novel approach by natural language processing for COVID-19 knowledge discovery. | Biomed J | 2022 | 35367669 | PubTator, text mining | PubMed |
| Construction and Validation of Two Hepatocellular Carcinoma-Progression Prognostic Scores Based on Gene Set Variation Analysis. | Front Cell Dev Biol | 2022 | 35356272 | PubTator, text mining | PubMed |
A Comprehensive Computational Investigation into the Conserved Virulent Proteins of Shigella species Unveils Potential Small-Interfering RNA Candidates as a New Therapeutic Strategy against Shigellosis. | Molecules | 2022 | 35335300 | PubTator, text mining | PubMed |
| New Insights on Metabolic and Genetic Basis of Migraine: Novel Impact on Management and Therapeutical Approach. | Int J Mol Sci | 2022 | 35328439 | PubTator, text mining | PubMed |
| 2-Aminothiophene derivatives as a new class of positive allosteric modulators of glucagon-like peptide 1 receptor. | Chem Biol Drug Des | 2022 | 35313084 | PubTator, text mining | PubMed |
| Targeted Delivery of Chemotherapeutic Agents for Osteosarcoma Treatment. | Front Oncol | 2022 | 35311145 | PubTator, text mining | PubMed |
| Durability of transgene expression after rAAV gene therapy. | Mol Ther | 2022 | 35283274 | PubTator, text mining | PubMed |
| A transcriptomic analysis based on aberrant methylation levels revealed potential novel therapeutic targets for nasopharyngeal carcinoma. | Ann Transl Med | 2022 | 35282089 | PubTator, text mining | PubMed |
| Gestational Perfluoroalkyl Substance Exposure and DNA Methylation at Birth and 12 Years of Age: A Longitudinal Epigenome-Wide Association Study. | Environ Health Perspect | 2022 | 35266797 | PubTator, text mining | PubMed |
| Modular Screening Reveals Driver Induced Additive Mechanisms of Baicalin and Jasminoidin on Cerebral Ischemia Therapy. | Front Cardiovasc Med | 2022 | 35265682 | PubTator, text mining | PubMed |
| Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate. | Proc Natl Acad Sci U S A | 2022 | 35263223 | PubTator, text mining | PubMed |
| Distribution of PACAP and PAC1 Receptor in the Human Eye. | J Mol Neurosci | 2022 | 35253081 | PubTator, text mining | PubMed |
| Analysis of the tumor immune environment identifies an immune gene set-based prognostic signature in non-small cell lung cancer. | Ann Transl Med | 2022 | 35242860 | PubTator, text mining | PubMed |
| Design and Synthesis of Brain Penetrant Glycopeptide Analogues of PACAP With Neuroprotective Potential for Traumatic Brain Injury and Parkinsonism. | Front Drug Discov (Lausanne) | 2022 | 35237767 | PubTator, text mining | PubMed |
| Hypoxia Is a Dominant Remodeler of the Effector T Cell Surface Proteome Relative to Activation and Regulatory T Cell Suppression. | Mol Cell Proteomics | 2022 | 35217172 | PubTator, text mining | PubMed |
| Human CD4+CD45RA+ T Cells Behavior after In Vitro Activation: Modulatory Role of Vasoactive Intestinal Peptide. | Int J Mol Sci | 2022 | 35216459 | PubTator, text mining | PubMed |
| Mechanisms Underlying the Expansion and Functional Maturation of β-Cells in Newborns: Impact of the Nutritional Environment. | Int J Mol Sci | 2022 | 35216239 | PubTator, text mining | PubMed |
| PACAP-38 Induces Transcriptomic Changes in Rat Trigeminal Ganglion Cells Related to Neuroinflammation and Altered Mitochondrial Function Presumably via PAC1/VPAC2 Receptor-Independent Mechanism. | Int J Mol Sci | 2022 | 35216232 | PubTator, text mining | PubMed |
| Refined Capsid Structure of Human Adenovirus D26 at 3.4 Å Resolution. | Viruses | 2022 | 35216007 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7433/papers?page=17